Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Themes | Quick Take |
|---|---|---|---|---|---|---|---|
Buyside Digest is not affiliated with, and does not endorse, Parnassus Mid Cap Growth Fund. This analysis is provided for institutional research purposes only and is not investment advice.
"Parnassus underperformed in Q1 on healthcare weakness and energy underweight. The fund is strategically repositioning around AI disruption, keeping semiconductor equipment exposure while exiting software names and adding infrastructure plays."
Parnassus Core Equity Fund returned -6.17% in Q1 2026, underperforming the S&P 500's -4.33% due to healthcare holdings and lack of energy exposure. The fund is navigating AI disruption by balancing exposure between AI beneficiaries and AI-resistant companies. Semiconductor equipment names Applied Materials and KLA were top contributors, benefiting from AI infrastructure spending. Healthcare holdings like Boston Scientific and life sciences tools companies underperformed on competitive and funding concerns. The managers made strategic portfolio changes, exiting software names ServiceNow and Workday due to AI uncertainty while adding infrastructure plays Old Dominion Freight Line and Vulcan Materials to benefit from reshoring trends. Geopolitical tensions in the Middle East created market volatility but the fund maintained its disciplined approach without event-driven positioning changes. Looking ahead, the managers expect earnings growth rather than multiple expansion to drive returns in 2026, remaining cautiously optimistic on strong fundamentals despite elevated geopolitical risks and AI-driven uncertainty creating greater market dispersion.
Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.
Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.
Market Conviction
High-conviction positioning: Parnassus underperformed in Q1 on healthcare weakness and energy underweight. The fund is strategically repositioning around AI disruption, keeping semiconductor equipment exposure...
Growth Outlook
Market outlook remains low conviction: Parnassus underperformed in Q1 on healthcare weakness and energy underweight. The fund is strategically repositioning around AI disruption, keeping semiconductor equipment exposure...
Risk Appetite
Risk appetite posture is very low conviction: Parnassus underperformed in Q1 on healthcare weakness and energy underweight. The fund is strategically repositioning around AI disruption, keeping semiconductor equipment exposure...
Capital Deployment
Manager actively deployed capital into high-conviction opportunities. Parnassus underperformed in Q1 on healthcare weakness and energy underweight. The fund is strategically repositioning around AI disruption, keeping semiconductor equipment exposure...
Forward Guidance
Forward guidance signal: Parnassus underperformed in Q1 on healthcare weakness and energy underweight. The fund is strategically repositioning around AI disruption, keeping semiconductor equipment exposure...
Language Signal
Tone analysis indicates low conviction language: Parnassus underperformed in Q1 on healthcare weakness and energy underweight. The fund is strategically repositioning around AI disruption, keeping semiconductor equipment exposure...
Perceived Risk
Perceived risk level is evaluated as moderate conviction. Parnassus underperformed in Q1 on healthcare weakness and energy underweight. The fund is strategically repositioning around AI disruption, keeping semiconductor equipment exposure...
Opportunity Density
Opportunity density index indicates moderate conviction actionable entry points. Parnassus underperformed in Q1 on healthcare weakness and energy underweight. The fund is strategically repositioning around AI disruption, keeping semiconductor equipment exposure...
Time Horizon
Investment time horizon reflects a moderate conviction orientation. Parnassus underperformed in Q1 on healthcare weakness and energy underweight. The fund is strategically repositioning around AI disruption, keeping semiconductor equipment exposure...
